21 May 2013
Keywords: positive, ph, data, serono, cladribine, results, phase
Article | 29 March 2004
Positive results from two Phase I trials of an oral formulation of cladribine, a potential new treatment for multiple sclerosis, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
29 March 2004
20 May 2013
© 2013 thepharmaletter.com